Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RZ5O
|
|||
| Drug Name |
Tetrazolyl urea derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-55
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NORTHEASTERN UNIVERSITY MAKRIYANNIS, Alexandros PANDARINATHAN, Lakshimpathi ZVONOK, Nikolai PARKKARI, Teija CHAPMAN, Lauren
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H16Cl3N5O
|
|||
| Canonical SMILES |
CN(CCCCCl)C(=O)N1N=C(N=N1)CC2=C(C=C(C=C2)Cl)Cl
|
|||
| InChI |
1S/C14H16Cl3N5O/c1-21(7-3-2-6-15)14(23)22-19-13(18-20-22)8-10-4-5-11(16)9-12(10)17/h4-5,9H,2-3,6-8H2,1H3
|
|||
| InChIKey |
OQUPYXJFXDHGPX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.